The record
| Class | metabolic |
|---|---|
| Also known as | hGH Frag 176-191, Fragment 176-191, Frag 176-191, Lipotropin |
| Chain length | - |
| Molecular weight | 1,817.1 Da |
| Half-life | ~3 minutes (estimated) |
| Route | SC |
| Studied for | None approved |
| Research use | Fat loss research, Metabolic studies |
| What has been shown | Reduces body fat in obese mice; Hyperglycemic effect in rats; No effect on lean mass; No IGF-1 elevation |
| How it works | C-terminal fragment of hGH believed to promote lipolysis and inhibit lipogenesis. Unlike AOD-9604, this is the unmodified linear fragment which may have different properties including potential hyperglycemic effects. |
| Patent status | Not patented |
| Regulatory status | Research chemical |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Fat Loss Signaling Environment (affection, 65%)
- Cognitive support (illness, 30%)
- Fat loss without muscle loss (illness, 60%)
- HIV-associated lipodystrophy (illness, 30%)
- Obesity/weight loss (illness, 60%)
- Prostate cancer (illness, 60%)
- Visceral adiposity reduction (illness, 30%)
- Weight gain or constant hunger (symptom, 75%)